A noninvasive ultrasound device restored heart rhythm in animal models and engineered human heart cells, paving the way for ...

Antiamyloid drugs clear amyloid plaques and modestly slow cognitive decline in patients with Alzheimer’s disease, but whether ...

An imaging-derived muscle-fat index predicts heart failure, cardiovascular deaths, and all-cause deaths more accurately than BMI and waist-based measures.

Roflumilast 0.05% (Zoryve), a topical phosphodiesterase-4 inhibitor, is currently approved for treating mild-to-moderate AD in children aged 2 years or older; it was approved for ...

In Canada, ED overcrowding, particularly with older adults, is a healthcare system failure that must be addressed across ...

Fascinating nervous system imaging reveals previously unseen obesity-related nerve damage in mice and humans — and some of it ...

New data suggest an approach that could improve the use of guideline-directed medical therapy among patients with heart ...

A network meta-analysis of 19 weight-loss drugs concludes that most obesity drugs don’t improve quality of life or cardiovascular health.

A new UK initiative aims to ensure AI is used safely and effectively, as early NHS experience shows both the promise and limits of AI-enabled skin cancer screening.

The EMA has alerted healthcare professionals to a small increased risk for meningioma with the progestogen-based contraceptives desogestrel and etonogestrel.

An AI-powered biomarker based on histology alone predicted survival among men with metastatic hormone-sensitive prostate cancer and identified those who benefitted from escalation to triplet therapy.

Data presented at EULAR 2026 confirm that tight disease control can lead to safe pregnancies but also expose a critical need ...